Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05EHJ
|
|||
| Former ID |
DIB012421
|
|||
| Drug Name |
IMOVAX
|
|||
| Synonyms |
IPOL; Poliovirus vaccine, Aventis SA; SP-059
Click to Show/Hide
|
|||
| Indication | Poliovirus infection [ICD-11: 1C8Y] | Approved | [1], [2] | |
| Company |
Aventis SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT02005536) Study of IMOVAX POLIO Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.